The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients

被引:10
作者
Gerencer, M
Burek, V
Crowe, BA
Barrett, NP
Dorner, F
机构
[1] Immuno AG Wien, Biomed Res Ctr, A-2304 Orth D, Austria
[2] Univ Hosp Infect Dis Dr Fran Mihalijevic, Dept Clin Immunol, Zagreb 10000, Croatia
关键词
HIV-1; pathology; complement activation; CD4+ T cell depletion; AIDS; C1-esterase inhibitor;
D O I
10.1006/mpat.1998.0233
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The substantial virus lysis was induced by HIV-l-infected patient serum and normal human complement serum in the presence of purified patient IgG. Non-infected CD4+ T cells coated with the whole virus or with a recombinant HIV-1 envelope gp120 and sensitised with patient IgG were also shown to be susceptible to complement-dependent lysis. The serum level of complement regulatory protein in a fluid phase, the C1-esterase inhibitor, was significantly correlated with serum concentration of C1q-circulating immune complexes (P=0.0062), but inversely with CD4+ T cell count (P < 0.0001). Accordingly, the disease progression in HIV-l-infected patients was significantly correlated with the level of complement activation as determined by serum level of C1-esterase inhibitor (P = 0.0001), and inversely correlated with CD4+ cell count (P < 0.0001) and gp120-specific antibody titre (P = 0.0086). These results strongly suggest that the complement activation by gp120-specific antibodies play a very important role in virus clearance, but also in depletion of infected as well as gp120-coated non-infected CD4+ bystander T cells during the course of HIV-1 infection. (C) 1998 Academic Press.
引用
收藏
页码:253 / 266
页数:14
相关论文
共 31 条
[1]   THE AIDS-ASSOCIATED RETROVIRUS IS NOT SENSITIVE TO LYSIS OR INACTIVATION BY HUMAN-SERUM [J].
BANAPOUR, B ;
SERNATINGER, J ;
LEVY, JA .
VIROLOGY, 1986, 152 (01) :268-271
[2]   Inhibition of classical complement activation by sera from HIV-1-positive patients [J].
Burek, V ;
Gerencer, M .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 81 (02) :114-121
[3]   CD4+ LYMPHOCYTE DEPLETION IN HIV-INFECTED PATIENTS IS ASSOCIATED WITH GP120-IMMUNOGLOBULIN-COMPLEMENT ATTACHMENT TO CD4+ CELLS [J].
DANIEL, V ;
SUSAL, C ;
PRODEUS, AP ;
WEIMER, R ;
ZIMMERMANN, R ;
HUTHKUHNE, A ;
OPELZ, G .
VOX SANGUINIS, 1993, 64 (01) :31-36
[4]  
Densen P, 1998, HUMAN COMPLEMENT SYS, P409
[5]   PREVALENCE OF CONGENITAL OR ACQUIRED COMPLEMENT DEFICIENCY IN PATIENTS WITH SPORADIC MENINGOCOCCAL DISEASE [J].
ELLISON, RT ;
KOHLER, PF ;
CURD, JG ;
JUDSON, FN ;
RELLER, LB .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (16) :913-916
[6]   ACQUIRED C1-INHIBITOR DEFICIENCY ASSOCIATED WITH ANTIIDIOTYPIC ANTIBODY TO MONOCLONAL IMMUNOGLOBULINS [J].
GEHA, RS ;
QUINTI, I ;
AUSTEN, KF ;
CICARDI, M ;
SHEFFER, A ;
ROSEN, FS .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (09) :534-540
[7]   Natural IgM antibodies in baby rabbit serum bind high-mannose glycans on HIV type 1 glycoprotein 120/160 and activate classic complement pathway [J].
Gerencer, M ;
Barrett, PN ;
Kistner, O ;
Mitterer, A ;
Dorner, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (07) :599-605
[8]   INFLAMMATORY MEDIATORS IN DEMYELINATING DISORDERS OF THE CNS AND PNS [J].
HARTUNG, HP ;
JUNG, SF ;
STOLL, G ;
ZIELASEK, J ;
SCHMIDT, B ;
ARCHELOS, JJ ;
TOYKA, KV .
JOURNAL OF NEUROIMMUNOLOGY, 1992, 40 (2-3) :197-210
[9]  
HENTGES F, 1992, CLIN EXP IMMUNOL, V88, P237, DOI 10.1111/j.1365-2249.1992.tb03067.x
[10]   Dynamics of HIV-1 replication in vivo [J].
Ho, DD .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (11) :2565-2567